Showing results (251-260 of 689) with videos related to
Sort By:
Pageof 69
The American Journal of Cardiology|May 1, 1985
Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery diseaseH D White, J F Polak, J Wynne, et al.American Journal of Clinical Pathology|December 1, 1988
Epithelioid sarcoma with diffuse bone marrow metastases and associated leukemoid reaction. A case report and brief literature reviewA E Rosenberg, J E Garber, W Bennett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trialM A Lew, K Kehoe, J Ritz, et al.Journal of the American Heart Association|March 26, 2013
Dynamic TIMI risk score for STEMISameer T Amin, David A Morrow, Eugene Braunwald, et al.European Heart Journal|February 3, 2005
Potent inhibition of thrombin with a monoclonal antibody against tissue factor (Sunol-cH36): results of the PROXIMATE-TIMI 27 trialDavid A Morrow, Sabina A Murphy, Carolyn H McCabe, et al.Journal of Hematotherapy|January 1, 1993
High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experienceL J Ayash, A Elias, C Wheeler, et al.Seminars in Oncology|February 1, 1990
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combinationB A Teicher, S A Holden, J P Eder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2V R Grann, W Whang, J S Jacobson, et al.The New England Journal of Medicine|October 27, 1994
Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarctionJ Z Ayanian, P J Hauptman, E Guadagnoli, et al.The American Journal of Cardiology|August 6, 2011
Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agenciesStephen D Wiviott, Nihar Desai, Sabina A Murphy, et al.Pageof 69